IPG1576, a potent small molecule inhibitor targeting MIF tautomerase specifically, has been shown to thwart MDSC formation in the tumor microenvironment effectively, thereby enhancing CD8+ T cell activity and markedly reducing pancreatic cancer growth (206). This evidence concerns the gene CD8A and familial pancreatic carcinoma.